MILINAZZO ALAN

Average Profitability
<0.0001%
Insider Buys Quantity
17
Insider Buys Sum
$1.91M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of MILINAZZO ALAN

The largest purchase of all time was on 2013-04-16 and amounted to 200000 shares of InspireMD, Inc. for $400,000.

Biography of MILINAZZO ALAN

No biography is available at this moment.

2015-03-09PurchaseInspireMD, Inc.
NSPR
President and CEO
250,000
0.5504%
$0.47$118,750-39.33%
2014-11-07PurchaseInspireMD, Inc.
NSPR
President and CEO
19,231
0.0512%
$1.30$25,000-76.61%
2014-05-12PurchaseInspireMD, Inc.
NSPR
President and CEO
14,200
0.0427%
$2.36$33,478-87.87%
2013-05-29PurchaseInspireMD, Inc.
NSPR
President and CEO
20,000
0.059%
$2.11$42,200
2013-05-28PurchaseInspireMD, Inc.
NSPR
President and CEO
10,000
0.0301%
$2.11$21,100
2013-04-16PurchaseInspireMD, Inc.
NSPR
President and CEO
200,000
0.645%
$2.00$400,000
2010-11-08PurchaseOrthofix Medical Inc.
OFIX
President & CEO
2,200
0.0122%
$26.59$58,498+24.17%
2008-08-15PurchaseOrthofix Medical Inc.
OFIX
President & CEO
15,250
0.09%
$22.61$344,803-21.37%
2008-05-09PurchaseOrthofix Medical Inc.
OFIX
President & CEO
9,200
0.0551%
$33.92$312,075-46.82%
2008-05-06PurchaseOrthofix Medical Inc.
OFIX
President & CEO
1,200
0.0068%
$35.83$43,000-52.3%
2006-12-01PurchaseOrthofix Medical Inc.
OFIX
President & CEO
2,350
0.0142%
$43.17$101,460+13.01%
2006-11-30PurchaseOrthofix Medical Inc.
OFIX
President & CEO
400
0.0024%
$43.15$17,260+12.95%
2006-11-01PurchaseOrthofix Medical Inc.
OFIX
President & CEO
1,250
0.0076%
$43.39$54,238+11.24%
2006-10-31PurchaseOrthofix Medical Inc.
OFIX
President & CEO
4,200
0.0253%
$44.13$185,358+7.93%
2005-11-17PurchaseOrthofix Medical Inc.
OFIX
President & CEO
3,000
0.0187%
$36.10$108,300+10.59%
2005-11-14PurchaseOrthofix Medical Inc.
OFIX
President & CEO
200
0.0013%
$37.36$7,472+7.2%
2005-11-02PurchaseOrthofix Medical Inc.
OFIX
President & CEO
1,000
0.0063%
$37.71$37,710+5.89%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.